Published in J Neurol Neurosurg Psychiatry on May 01, 1993
Structural gray and white matter changes in patients with HIV. J Neurol (2011) 1.22
Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging (2010) 1.14
Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol (1994) 1.14
Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther (2014) 1.08
Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One (2013) 1.05
Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients. Brain Imaging Behav (2010) 1.01
Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). Mol Neurodegener (2011) 0.92
HIV-1-infected astrocytes and the microglial proteome. J Neuroimmune Pharmacol (2008) 0.92
Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders. J Neuroimmune Pharmacol (2009) 0.89
Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol (1996) 0.88
ER-β mediates 17β-estradiol attenuation of HIV-1 Tat-induced apoptotic signaling. Synapse (2010) 0.85
Neuronal expression of human immunodeficiency virus type 1 env proteins in transgenic mice: distribution in the central nervous system and pathological alterations. J Virol (1995) 0.81
PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins. PLoS One (2010) 0.81
Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons. J Neurovirol (2009) 0.79
14-3-3s are potential biomarkers for HIV-related neurodegeneration. J Neurovirol (2012) 0.78
In vivo modeling of HIV-1 mediated neurodegeneration. Am J Pathol (1996) 0.78
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda. J Neurovirol (2016) 0.76
Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIV. J Neurovirol (2015) 0.75
Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats. PLoS One (2017) 0.75
Identifying HIV-induced subgraph patterns in brain networks with side information. Brain Inform (2015) 0.75
The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc (1984) 7.61
The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science (1988) 6.51
The AIDS dementia complex: II. Neuropathology. Ann Neurol (1986) 5.61
Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J Microsc (1986) 5.13
HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science (1990) 3.41
Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol (1981) 3.18
Glutamate: a neurotransmitter in mammalian brain. J Neurochem (1984) 2.82
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol (1988) 2.26
Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A (1988) 2.24
Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (1988) 2.17
Neocortical cell counts in normal human adult aging. Ann Neurol (1987) 2.16
Neocortical damage during HIV infection. Ann Neurol (1991) 2.15
Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol (1991) 2.08
Total number of neurons and glial cells in human brain nuclei estimated by the disector and the fractionator. J Microsc (1988) 2.00
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
The nucleator. J Microsc (1988) 1.78
Organization of the cerebral cortex. III. A study of aging in the human cerebral cortex. J Comp Neurol (1955) 1.76
Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron (1991) 1.73
Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest (1991) 1.71
Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodefic Rev (1988) 1.43
N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues. J Neurochem (1972) 1.38
HIV-related neurotoxicity. Brain Pathol (1991) 1.37
Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo. J Clin Invest (1988) 1.26
The total number of neurons in the human neocortex unbiasedly estimated using optical disectors. J Microsc (1990) 1.26
Cell counts in human cerebral cortex in normal adults throughout life using an image analysing computer. J Neurol Sci (1980) 1.06
Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J Comput Assist Tomogr (1990) 0.97
The involvement of the cerebral cortex in human immunodeficiency virus encephalopathy: a morphological and immunohistochemical study. Acta Neuropathol (1990) 0.92
Similarities of viral proteins to toxins that interact with monovalent cation channels. AIDS (1991) 0.86
Vasoactive intestinal polypeptide (VIP)-sensitive adenylate cyclase in rat brain: regional distribution and localization on hypothalamic neurons. J Pharm Pharmacol (1980) 0.82
Cell counts in the human cerebral cortex using a traditional and an automatic method. J Neurol Sci (1975) 0.81
The regional distribution of receptors for vasoactive intestinal polypeptide (VIP) in the rat central nervous system. Brain Res (1985) 0.80
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci (1989) 4.01
Prion dementia without characteristic pathology. Lancet (1990) 3.66
Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett (1998) 3.26
Corticobasal degeneration. Brain (1989) 3.20
Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature (1996) 3.09
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol (1996) 2.68
Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A (2000) 2.50
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol (1999) 1.89
Diagnosing dementia: do we get it right? BMJ (1988) 1.85
Brain capillary endothelial cells in vitro lack surface IgG Fc receptors. Neurosci Lett (1986) 1.74
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry (1994) 1.60
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
Diagnostic criteria for corticobasal degeneration. J Neurol Neurosurg Psychiatry (2000) 1.48
Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain (2000) 1.43
The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain (1994) 1.41
Recommended minimum data to be collected in research studies on Alzheimer's disease. The MRC (UK) Alzheimer's Disease Workshop Steering Committee. J Neurol Neurosurg Psychiatry (1989) 1.41
The fine structure of periventricular pleomorphic gliomas induced transplacentally by N-ethyl-N-nitrosourea in BD-IX rats. With a note on their origin. J Neurol Sci (1972) 1.38
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
Brain tissue banks in psychiatric and neurological research. J Clin Pathol (1996) 1.38
Characterization of the human cell line TE671. Carcinogenesis (1989) 1.34
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol (1996) 1.32
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci (1992) 1.21
Studies of the morphology and tumorigenicity of experimental brain tumours in tissue culture. Br J Exp Pathol (1976) 1.20
Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport (2001) 1.19
Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-gamma, tumour necrosis factor and interleukin-1. Immunology (1988) 1.17
The origin of experimental brain tumours: a sequential study. Experientia (1976) 1.17
The development of experimental brain tumours. A sequential light and electron microscope study of the subependymal plate. I. Early lesions (abnormal cell clusters). Acta Neuropathol (1979) 1.14
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14
Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol (1994) 1.14
Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci (1999) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similar? Lancet (1997) 1.14
Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology (2000) 1.13
Prion protein immunocytochemistry--UK five centre consensus report. Neuropathol Appl Neurobiol (1997) 1.13
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol (1996) 1.12
Microglia and the pathogenesis of spongiform encephalopathies. Brain Res Brain Res Rev (2001) 1.11
Distribution and fine structural analysis of undifferentiated cells in the primate subependymal layer. J Anat (1991) 1.10
Pick's disease is associated with mutations in the tau gene. Ann Neurol (2000) 1.10
The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis. J Neurol Sci (1981) 1.09
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol (1999) 1.07
Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J Neurol Neurosurg Psychiatry (1993) 1.05
Chemical carcinogenesis in the nervous system. Int Rev Exp Pathol (1976) 1.05
Quantitative analysis of tau isoform transcripts in sporadic tauopathies. Brain Res Mol Brain Res (2005) 1.04
beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol (1999) 1.04
HIV-associated brain pathology in the United Kingdom: an epidemiological study. AIDS (1997) 1.03
Alien hand sign in association with Alzheimer's histopathology. J Neurol Neurosurg Psychiatry (1993) 1.01
A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies. Ann Neurol (2000) 1.00
TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (2000) 0.99
Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett (1992) 0.99
Immunocytochemistry of cerebellar astrocytomas: with a special note on Rosenthal fibres. Acta Neuropathol (1985) 0.98
Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol (2000) 0.98
The role of glutamine synthetase in the diagnosis of cerebral tumours. Neuropathol Appl Neurobiol (1982) 0.96
Correlation of MRI and neuropathology in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.96
The vasculature of experimental brain tumours. Part 2. A quantitative assessment of morphological abnormalities. J Neurol Sci (1981) 0.94
Macrophages in brain tumours induced transplacentally by N-ethyl-N-nitrosourea in rats: an electron-microscope study. J Pathol (1975) 0.94
Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system. Neuroscience (1989) 0.94
Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated. Biochem J (1991) 0.94
Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease. Psychiatry Clin Neurosci (2000) 0.94
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2008) 0.93
A prion disease with a novel 96-base pair insertional mutation in the prion protein gene. Neurology (1996) 0.93
An electron microscope study of reacting astrocytes in gliomas induced by n-ethyl-n-nitrosourea in rats. Acta Neuropathol (1974) 0.93
A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration. Exp Neurol (2000) 0.93
Cell lines (VMDk) derived from a spontaneous murine astrocytoma. Morphological and immunocytochemical characterization. J Neurol Sci (1983) 0.93
Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease. Neurosci Lett (1997) 0.92
Cerebral damage in paraquat poisoning. Histopathology (1980) 0.92
Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathol (1998) 0.91
Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature (1988) 0.91
Ultrastructural examination is essential for diagnosis of papillary meningioma. Histopathology (2001) 0.91
The fine structure of blood vessels in ethylnitrosourea-induced tumours of the rat nervous system: with special reference to the breakdown of the blood-brain barrier. Br J Exp Pathol (1976) 0.91
Cell proliferation in the subependymal layer of the postnatal marmoset, Callithrix jacchus. Brain Res Dev Brain Res (1990) 0.91
Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as 'cotton wool' plaques. Neuropathol Appl Neurobiol (2001) 0.91
A quantitative study of the pathological changes in the cerebellum in 15 cases of variant Creutzfeldt-Jakob disease (vCJD). Neuropathol Appl Neurobiol (2009) 0.90
What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? Neuropathology (2001) 0.90
Norrie disease and peripheral venous insufficiency. Br J Ophthalmol (2004) 0.89
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus. Vision Res (2002) 0.89
Spatial correlations between the vacuolation, prion protein deposits, and surviving neurons in the cerebral cortex in sporadic Creutzfeldt-Jakob disease. Neuropathology (2001) 0.89
Retained intravitreal lens fragments after phacoemulsification: a clinicopathological correlation. Br J Ophthalmol (1999) 0.88
Vitreous amyloidosis in alanine 71 transthyretin mutation. Br J Ophthalmol (2005) 0.88
Fine structural localisation of acid phosphatase in neural tumours induced by N-ethyl-N-nitrosourea in rats. Acta Neuropathol (1974) 0.88
Two unusual osteogenic orbital tumors: presumed parosteal osteosarcomas of the orbit. Ophthalmology (2001) 0.88